Article Information
History
- September 14, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Joel Iko-ojo Oguche1,2,3,4,
- Rebecca Olajumoke Bolaji1,
- Josiah Ademola Onaolapo1,
- Samuel Eneojo Abah*,2,3,4,5,6,7,8,
- Vivian Gga Kwaghe9,
- Shedrack Egbunu Akor2,3,7,8,10,
- Sarah Shaibu2,3,4,8,
- Tijani Salami2,3,11 and
- Gloria Eleojo Eneojo-Abah2,3,4,12
- 1Department of Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, Ahmadu Bello University Zaria, Kaduna State, Nigeria
- 2British Community Hospital, Gyedna, Niger State, Nigeria
- 3EBIHAS Virtual Research Institute and Training, United Kingdom/Nigeria
- 4HolyNations International Ministries, United Kingdom/Nigeria
- 5Health and Life Sciences, Coventry University, CUL, United Kingdom
- 6The Francis Crick Institute, London, United Kingdom
- 7IBB University, Lapai, Niger State, Nigeria
- 8British Pathodiagnostic and Biotechnology laboratory, Gyedna, Nigeria
- 9Department of Internal Medicine, University of Abuja Teaching Hospital, Nigeria
- 10Department of Chemical Pathology, Kogi State University, Nigeria
- 11Health Services Department, Federal University Minna, Niger State
- 12London North-West Healthcare University NHS Trust, United Kingdom
- ↵*Corresponding Author Samuel Eneojo Abah, samuelabah{at}gmail.com